4.7 Article

Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment

期刊

INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 17, 期 -, 页码 953-967

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S340926

关键词

multifunctional carboxymethyl chitosan; targeting delivery; endosomal escape; gene silencing; anti-tumor therapy

资金

  1. National Natural Science Foundation of China [U1504527]
  2. Science and Technology Research Key Project of the Henan Science and Technology Commission [CXJD2020001]

向作者/读者索取更多资源

The researchers prepared a multifunctional siRNA delivery system (CHCE/siRNA nanoparticles) by self-assembling carboxymethyl chitosan modified with histidine, cholesterol, and anti-EGFR antibody. The nanoparticles showed tumor-targeting and pH response capabilities, allowing for efficient gene silencing and tumor inhibition both in vitro and in vivo.
Purpose: In order to overcome the biological barriers at all levels and enhance the delivery efficiency of siRNA, we have prepared a multifunctional siRNA delivery system (CHCE/siRNA nanoparticles) through self-assembly of the carboxymethyl chitosan modified with histidine, cholesterol, and anti-EGFR antibody (CHCE). Methods: The morphology of CHCE/siRNA NPs was detected by dynamic light scattering and scanning electron microscope. In vitro, we assessed the tumor-targeting, cellular uptake, and endosomal escape by flow cytometry and confocal laser scanning microscopy, confirming the CHCE/siRNA NPs functions in gene silencing and cell killing ability. In vivo, we examined the biodistribution of the CHCE/siRNA NPs by the IVIS imaging system and confirmed the therapeutic effect of NPs in the nude mouse tumor model. Results: The CHCE/siRNA NPs exhibited nanosized spherical with narrow size distribution. In vitro, the CHCE/siRNA NPs incorporated a dual capability of tumor targeting and pH response that could facilitate cellular bind, cellular uptake, and endosomal escape. The CHCE/ siRNA NPs could effectively silence the vascular endothelial growth factor A (VEGFA) to cause cell apoptosis and inhibit proliferation. In vivo, the CHCE/siRNA NPs could target tumor sites to knock down VEGFA and achieve a better anti-tumor effect. Conclusion: We successfully prepared a novel siRNA delivery system with the double capability of tumor targeting and pH response, which can break through the biological barriers to penetrate deep into tumors and achieve better therapeutic tumor effects, providing a new ideal for siRNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据